Brand Engagement Network Advances Skye Salud to Phase 2
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 23 2026
0mins
Brand Engagement Network announced the advancement of Skye Salud to Phase 2 of its clinical evaluation program in Mexico. Developed through a collaboration among the company, Grupo Skye, and Knobloch Information Group, Skye Salud is an AI-powered medical evidence platform that leverages trusted medical literature, clinical guidelines, and other authoritative sources to support evidence-based clinical information retrieval.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BNAI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BNAI
About BNAI
Brand Engagement Network Inc. is an artificial intelligence company focused on the engagement layer of artificial intelligence (AI), where human interaction connects directly to enterprise systems, workflows, and real-world outcomes. Through its secure, enterprise-grade conversational AI solutions, it enables organizations to connect human intent to data, systems, workflows, and execution across their operations. The Company's technology is powered by its proprietary Engagement Language Model (ELM), which is designed to operate within secure, closed-loop environments using organization-approved data and embedded governance and compliance controls. Its AI is built on a foundation of advanced modules spanning perception, understanding, and response, with capabilities including natural language processing (NLP), multisensory awareness, sentiment and environmental analysis, and real-time personalization. Its AI Agents can connect to client's data systems to access approved information.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Brand Engagement Network Acquires Cataneo to Enhance AI Platform
- Acquisition Overview: Brand Engagement Network (BNAI) completed its acquisition of Cataneo GmbH on June 30, 2026, with Cataneo generating over €8.6 million in revenue in 2025, thereby enhancing BNAI's market position in enterprise AI software.
- Platform Integration: Cataneo's MYDAS platform manages over €6 billion in advertising inventory, and BNAI plans to integrate its proprietary Engagement Language Model (ELM™) into the Cataneo platform to enhance advertising operations and decision-making efficiency, further promoting the application of enterprise AI.
- Strengthened Customer Relationships: The acquisition not only provides BNAI with long-standing customer relationships and critical workflows but also enables it to promote AI-driven enterprise solutions among existing customers while expanding into other industries, thereby enhancing market competitiveness.
- Leadership Changes: Cataneo co-founder Christian Unterseer has joined BNAI's Board of Directors, with integration efforts underway to ensure uninterrupted customer service, demonstrating BNAI's commitment to continuous innovation and customer support.
See More
Brand Engagement Network Acquires Cataneo to Enhance AI Capabilities
- Acquisition Overview: Brand Engagement Network (BNAI) completed its acquisition of Cataneo GmbH on June 30, 2026, with Cataneo generating over €8.6 million in revenue in 2025 and managing more than €6 billion in advertising inventory, thereby enhancing BNAI's market position in the global advertising and media sector.
- Technology Integration: The acquisition aims to integrate BNAI's proprietary Engagement Language Model (ELM™) with Cataneo's platform to enhance advertising operations, audience intelligence, and workflow automation, thereby driving the application of enterprise AI within the advertising ecosystem.
- Customer Base Expansion: Cataneo's established commercial platform provides BNAI with a channel to deploy AI solutions to existing customers while creating opportunities for future expansion into other industries, which is expected to further enhance customer retention and revenue stability.
- Leadership Changes: Cataneo co-founder Christian Unterseer has joined BNAI's Board of Directors, with integration efforts underway to ensure uninterrupted customer service, indicating that the synergy between the two companies will deliver greater value to clients.
See More
Skye Salud Advances to Phase 2 Clinical Evaluation
- Clinical Evaluation Progress: Following the successful completion of Phase 1 rheumatology testing, Skye Salud has advanced to Phase 2 evaluation, which aims to expand testing into primary care use cases, expected to significantly enhance the platform's ability to access clinical information across Mexico and Latin America.
- AI Technology Application: The platform leverages BEN's enterprise-grade AI capabilities, Grupo Skye's innovative leadership in Latin America, and KNOBLOCH Information Group's trusted relationships within Mexico's healthcare community, aiming to optimize the retrieval of medical evidence through AI to improve service efficiency and quality.
- Market Opportunity: As one of the largest healthcare markets in Latin America, Mexico presents a significant opportunity for evaluating AI-enabled access to medical evidence, with the Phase 2 expansion expected to provide critical insights for future product development and commercialization planning.
- Strategic Collaboration: The collaboration among BEN, Grupo Skye, and KNOBLOCH Information Group creates a unique opportunity to evaluate how trusted medical evidence can be accessed more efficiently through AI while ensuring transparency and rigorous evidence standards, driving innovation in the healthcare sector.
See More
Skye Salud Advances to Phase 2 Evaluation in Primary Care
- Clinical Evaluation Progress: Following the successful completion of Phase 1 rheumatology testing, Skye Salud has advanced to Phase 2 evaluation, aimed at expanding testing into primary care use cases, which is expected to enhance the platform's performance and applicability across a broader range of clinical topics.
- AI Technology Application: The platform leverages BEN's enterprise-grade AI capabilities, Grupo Skye's leadership in AI innovation across Latin America, and KNOBLOCH's trusted relationships within Mexico's healthcare community to optimize access to medical evidence through AI, thereby improving the accessibility of clinical information.
- Market Potential: As one of the largest healthcare markets in Latin America, Mexico presents a significant opportunity for evaluating AI-enabled access to medical evidence, with the Phase 2 expansion set to provide valuable insights for future product development and commercialization planning.
- Strategic Collaboration: The partnership among BEN, Grupo Skye, and KNOBLOCH not only provides an evaluation framework for the platform's clinical coverage and evidence support capabilities but also ensures that stringent evidence standards and transparency are maintained during the expansion, reflecting a long-term commitment to the healthcare industry.
See More
Brand Engagement Network Selected for Russell 3000 Index
- Russell 3000 Inclusion: Brand Engagement Network (BNAI) announced its selection for membership in the Russell 3000 index as part of the 2026 Russell U.S. Indexes reconstitution, effective at the close of U.S. markets on June 26, 2026, which is expected to enhance the company's visibility and market recognition among investors.
- Market Capitalization Ranking: The annual Russell U.S. Indexes reconstitution evaluates the largest U.S. stocks as of April 30 and ranks them by total market capitalization, indicating BNAI's relative strength in the market and potentially attracting more institutional investor interest.
- Financial Performance Concerns: Despite BNAI's inclusion in a significant index, its revenue remains minimal while dilution continues to rise, which could negatively impact long-term shareholder value, prompting investors to monitor improvements in profitability.
- Acquisition Strategy: BNAI plans to acquire Cataneo for $19.5 million, which may provide new growth opportunities for the company, but it also raises concerns regarding the challenges of post-acquisition integration and its impact on financial health.
See More
Brand Engagement Network Joins Russell 3000 Index
- Inclusion in Russell 3000: Brand Engagement Network Inc. (BNAI) has been selected for membership in the 2026 Russell U.S. Indexes reconstitution, effective at the close of U.S. markets on June 26, 2026, marking a significant milestone in the company's public journey.
- Market Coverage Expansion: The Russell 3000 Index includes approximately 3,000 of the largest U.S. public companies, representing about 98% of the investable U.S. equity market, and BEN's inclusion will significantly enhance its visibility among investors.
- Technological Edge: BEN focuses on providing secure, enterprise-grade AI solutions for regulated industries such as healthcare and financial services, aiming to connect organizations, brands, and consumers through intelligent experiences that drive meaningful outcomes.
- Investor Confidence Boost: CEO Tyler Luck stated that joining the Russell indexes not only enhances the company's market image but also strengthens interactions with institutional investors, further driving the company's long-term growth strategy.
See More
Brand Engagement Network Acquires Cataneo to Enhance AI Platform
- Acquisition Overview: Brand Engagement Network (BNAI) completed its acquisition of Cataneo GmbH on June 30, 2026, with Cataneo generating over €8.6 million in revenue in 2025, thereby enhancing BNAI's market position in enterprise AI software.
- Platform Integration: Cataneo's MYDAS platform manages over €6 billion in advertising inventory, and BNAI plans to integrate its proprietary Engagement Language Model (ELM™) into the Cataneo platform to enhance advertising operations and decision-making efficiency, further promoting the application of enterprise AI.
- Strengthened Customer Relationships: The acquisition not only provides BNAI with long-standing customer relationships and critical workflows but also enables it to promote AI-driven enterprise solutions among existing customers while expanding into other industries, thereby enhancing market competitiveness.
- Leadership Changes: Cataneo co-founder Christian Unterseer has joined BNAI's Board of Directors, with integration efforts underway to ensure uninterrupted customer service, demonstrating BNAI's commitment to continuous innovation and customer support.
See More
Brand Engagement Network Acquires Cataneo to Enhance AI Capabilities
- Acquisition Overview: Brand Engagement Network (BNAI) completed its acquisition of Cataneo GmbH on June 30, 2026, with Cataneo generating over €8.6 million in revenue in 2025 and managing more than €6 billion in advertising inventory, thereby enhancing BNAI's market position in the global advertising and media sector.
- Technology Integration: The acquisition aims to integrate BNAI's proprietary Engagement Language Model (ELM™) with Cataneo's platform to enhance advertising operations, audience intelligence, and workflow automation, thereby driving the application of enterprise AI within the advertising ecosystem.
- Customer Base Expansion: Cataneo's established commercial platform provides BNAI with a channel to deploy AI solutions to existing customers while creating opportunities for future expansion into other industries, which is expected to further enhance customer retention and revenue stability.
- Leadership Changes: Cataneo co-founder Christian Unterseer has joined BNAI's Board of Directors, with integration efforts underway to ensure uninterrupted customer service, indicating that the synergy between the two companies will deliver greater value to clients.
See More
Skye Salud Advances to Phase 2 Clinical Evaluation
- Clinical Evaluation Progress: Following the successful completion of Phase 1 rheumatology testing, Skye Salud has advanced to Phase 2 evaluation, which aims to expand testing into primary care use cases, expected to significantly enhance the platform's ability to access clinical information across Mexico and Latin America.
- AI Technology Application: The platform leverages BEN's enterprise-grade AI capabilities, Grupo Skye's innovative leadership in Latin America, and KNOBLOCH Information Group's trusted relationships within Mexico's healthcare community, aiming to optimize the retrieval of medical evidence through AI to improve service efficiency and quality.
- Market Opportunity: As one of the largest healthcare markets in Latin America, Mexico presents a significant opportunity for evaluating AI-enabled access to medical evidence, with the Phase 2 expansion expected to provide critical insights for future product development and commercialization planning.
- Strategic Collaboration: The collaboration among BEN, Grupo Skye, and KNOBLOCH Information Group creates a unique opportunity to evaluate how trusted medical evidence can be accessed more efficiently through AI while ensuring transparency and rigorous evidence standards, driving innovation in the healthcare sector.
See More
Skye Salud Advances to Phase 2 Evaluation in Primary Care
- Clinical Evaluation Progress: Following the successful completion of Phase 1 rheumatology testing, Skye Salud has advanced to Phase 2 evaluation, aimed at expanding testing into primary care use cases, which is expected to enhance the platform's performance and applicability across a broader range of clinical topics.
- AI Technology Application: The platform leverages BEN's enterprise-grade AI capabilities, Grupo Skye's leadership in AI innovation across Latin America, and KNOBLOCH's trusted relationships within Mexico's healthcare community to optimize access to medical evidence through AI, thereby improving the accessibility of clinical information.
- Market Potential: As one of the largest healthcare markets in Latin America, Mexico presents a significant opportunity for evaluating AI-enabled access to medical evidence, with the Phase 2 expansion set to provide valuable insights for future product development and commercialization planning.
- Strategic Collaboration: The partnership among BEN, Grupo Skye, and KNOBLOCH not only provides an evaluation framework for the platform's clinical coverage and evidence support capabilities but also ensures that stringent evidence standards and transparency are maintained during the expansion, reflecting a long-term commitment to the healthcare industry.
See More
Brand Engagement Network Selected for Russell 3000 Index
- Russell 3000 Inclusion: Brand Engagement Network (BNAI) announced its selection for membership in the Russell 3000 index as part of the 2026 Russell U.S. Indexes reconstitution, effective at the close of U.S. markets on June 26, 2026, which is expected to enhance the company's visibility and market recognition among investors.
- Market Capitalization Ranking: The annual Russell U.S. Indexes reconstitution evaluates the largest U.S. stocks as of April 30 and ranks them by total market capitalization, indicating BNAI's relative strength in the market and potentially attracting more institutional investor interest.
- Financial Performance Concerns: Despite BNAI's inclusion in a significant index, its revenue remains minimal while dilution continues to rise, which could negatively impact long-term shareholder value, prompting investors to monitor improvements in profitability.
- Acquisition Strategy: BNAI plans to acquire Cataneo for $19.5 million, which may provide new growth opportunities for the company, but it also raises concerns regarding the challenges of post-acquisition integration and its impact on financial health.
See More
Brand Engagement Network Joins Russell 3000 Index
- Inclusion in Russell 3000: Brand Engagement Network Inc. (BNAI) has been selected for membership in the 2026 Russell U.S. Indexes reconstitution, effective at the close of U.S. markets on June 26, 2026, marking a significant milestone in the company's public journey.
- Market Coverage Expansion: The Russell 3000 Index includes approximately 3,000 of the largest U.S. public companies, representing about 98% of the investable U.S. equity market, and BEN's inclusion will significantly enhance its visibility among investors.
- Technological Edge: BEN focuses on providing secure, enterprise-grade AI solutions for regulated industries such as healthcare and financial services, aiming to connect organizations, brands, and consumers through intelligent experiences that drive meaningful outcomes.
- Investor Confidence Boost: CEO Tyler Luck stated that joining the Russell indexes not only enhances the company's market image but also strengthens interactions with institutional investors, further driving the company's long-term growth strategy.
See More
